As per the regulatory filing, pemetrexed is used to treat certain types of cancers such as lung cancer, mesothelioma. It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.
The drug will be manufactured at the formulation manufacturing facility at Zydus Hospira, Ahmedabad.
Zydus Cadila now has 319 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY2003-04.
At around 3.11 pm, Cadila was trading at Rs624.10 per piece up by 1.04% on Sensex.